Czirr James C's Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Apr 25, 2024
- Accession no.
- 0001493152-24-015877
- Filed
- Apr 25, 2024
- Trade date
- Apr 22-23, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $76.5K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Czirr James CCIK 0001260641 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | Common Stock | SSaleDisposed | −21,323 | $3.06 | −$65,248.38 | 5,925,884 | Indirect | |
| Apr 23, 2024 | Common Stock | SSaleDisposed | −3,677 | $3.06 | −$11,251.62 | 5,922,207 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.